Replies to post #13798 on Inovio Pharmaceuticals Inc (INO)

[Ubertino]

Dr. Kim says Inovio has received a total of $65 million in funding from DARPA, the NIH, and other collaborators to develop these novel DNA-based monoclonal therapies to treat Ebola infection, infections against influenza, HIV, and Zika. (PV)

http://www.pharmavoice.com/article/2017-2-zika-research/

Great support!!!

It takes money to make money.